Cidara Therapeutics, Inc. (CDTX)
Delisted
8 Jan 2026
NASDAQ (CM) NASDAQ (CM) Primary $
221. 38
0
0%
$
5.61B Market Cap
- P/E Ratio
- Div Yield
2.69M Volume
-0.31 Eps
$ 221.38
Previous Close Investors:
Day Range
221.38 221.38
Year Range
15.22 221.42
Want to track CDTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cidara Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 26 | $3,865.73 | $2,489.07 | -$1,376.66 | -35.61% |
 Michael Byun SageView Advisory Group LLC | 9 | $1,989 | $1,989 | - | - |
 Ryan Visniski Bryce Point Capital, LLC | 3,977 | $380,838 | $380,838 | - | - |
